Dale G. Ando
2014
In 2014, Dale G. Ando earned a total compensation of $1.3M as Vice President, Therapeutic Development and Chief Medical Officer at Sangamo Biosciences, a 3% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $143,220 |
|---|---|
| Option Awards | $404,895 |
| Salary | $440,000 |
| Stock Awards | $351,750 |
| Total | $1,339,865 |
Ando received $440K in salary, accounting for 33% of the total pay in 2014.
Ando also received $143.2K in non-equity incentive plan, $404.9K in option awards and $351.8K in stock awards.
Rankings
In 2014, Dale G. Ando's compensation ranked 6,283rd out of 13,032 executives tracked by ExecPay. In other words, Ando earned more than 51.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,283 out of 13,032 | 52nd |
Division Manufacturing | 2,289 out of 4,966 | 54th |
Major group Chemicals And Allied Products | 769 out of 1,686 | 54th |
Industry group Drugs | 602 out of 1,365 | 56th |
Industry Biological Products, Except Diagnostic Substances | 115 out of 236 | 51st |
Source: SEC filing on April 25, 2016.
Ando's colleagues
We found four more compensation records of executives who worked with Dale G. Ando at Sangamo Biosciences in 2014.